Abstract 1241: Enhancing NK cell therapy for head and neck cancer within the solid tumor microenvironment using a B7H3-targeting tri-specific killer engager (TriKE)Melissa Khaw, Jeffrey S. Miller, Nicholas A. Zorko et al.|Cancer Research|2024Cited by 0